Synergistic value of systemic inflammatory and tumor markers in predicting pretreatment distant metastasis of gastric cancer

Figure 1 Nomogram model for predicting the risk of distant metastasis in patients with gastric adenocarcinoma. CA19-9: Carbohydrate antigen 19-9; NE: Neutrophils; LY: Lymphocytes.

Figure 2 Receiver operating characteristic curves of the nomogram model for predicting the risk of metastasis in patients with gastric adenocarcinoma. A: Training set; B: Validation set. ROC: Receiver operating characteristic curves; AUC: Area under the curve.

Figure 3 Calibration curves comparing the predicted risk of metastasis by the nomogram model with the actual incidence in patients with gastric adenocarcinoma. A: Training set; B: Validation set.

Figure 4  Decision curve analysis of the nomogram model for predicting the risk of metastasis and the actual incidence in patients with gastric adenocarcinoma.